NO CME CREDIT - ATTENDANCE ONLY

Join Zoom Meeting
https://mc-meet.zoom.us/j/95869608121?pwd=NG9GaG5JWE44eGpSckdRWHFSNnVkUT09
 
Meeting ID: 958 6960 8121
Passcode: 636276

Pediatrics
Marc Patterson, M.D.
"Newly Approved therapies for Niemann-Pick disease, type C"

Learning Objectives:
Upon conclusion of this activity, participants will be able to:

• Recognize the presentations of Niemann-Pick disease, type C (NPC)
• Describe the diagnostic testing for NPC
• Assess the therapeutic approaches to NPC

Dr. Patterson has the following relevant financial relationships to disclose: Consulting: Azafaros, IntraBio, ScenicBio, Zevra; Editorial support: Wolters-Kluwer (Up-To-Date); Sage (Journal of Child Neurology); Research: Azafaros, Glycomine, Idorsia, Maggie's Pearl, Orphazyme/Kempharm/Zevra; Stock: IntraBio and does intend to discuss the following off-label/investigative use of Pharmaceuticals or Instruments: Actelion/Idorsia – Miglustat; Mandos – Adrabetadex; Azafaros - Nizubaglustat 

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.